300204.SZ
舒泰神
SZSE · Healthcare · C 制造业 · CN
CNY 21.00
−5.32%Year over year
Reported trailing growth
- Revenue
- -30.4%
- EBITDA
- —
- EBIT
- —
- EPS
- +41.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -26.2%
- EBITDA
- —
- EBIT
- —
- Net income
- +46.3%
- EPS
- +46.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026